RiboTargets and J&J PRI seek new antibiotics
UK biotech company RiboTargets Ltd. (researching anti-infectives that act on RNA targets) will ally with the RW Johnson Pharmaceutical Research Institute (PRI, part of Johnson & Johnson to discover novel antibiotics.
Drug Discovery Tools
- Molecular Diversity
- Drug Discovery Tools
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.